← Product Code [HWC](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HWC) · K200124 # InCore MPJ System (K200124) _Nextremity Solutions, Inc. · HWC · May 13, 2020 · Orthopedic · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HWC/K200124 ## Device Facts - **Applicant:** Nextremity Solutions, Inc. - **Product Code:** [HWC](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HWC.md) - **Decision Date:** May 13, 2020 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 888.3040 - **Device Class:** Class 2 - **Review Panel:** Orthopedic - **Attributes:** Therapeutic ## Intended Use The Nextremity Solutions InCore® MPJ System is a three-part construct intended for internal fixation for First Metatarsophalangeal Joint Arthrodesis (also known as 1st MPJ Fusion). ## Device Story InCore MPJ System is a three-part orthopedic implant construct for 1st Metatarsophalangeal Joint Arthrodesis. System comprises a post, two headless compression screws, and a post plug screw. Surgeon inserts post into metatarsal head; compression screws are placed through phalange into post to maintain bone apposition during fusion; post plug screw prevents tissue ingrowth. Used in clinical/surgical settings by orthopedic surgeons. Provides rigid internal fixation to facilitate bone fusion. Benefits include stabilization of the joint to promote healing. ## Clinical Evidence No clinical data. Substantial equivalence demonstrated via bench testing, including axial pull-out strength, torque to failure, and static/dynamic 3-point bend testing per ASTM F543-13, ASTM F1264-16, and ASTM F382-17. Endotoxin testing performed per USP/European Pharmacopeia standards. ## Technological Characteristics Construct consists of a post, headless compression screws, and a post plug screw. Materials: Color anodized Ti-6Al-4V alloy (ASTM F-136). Mechanical testing performed per ASTM F543-13, ASTM F1264-16, and ASTM F382-17. System includes accessory instruments for site preparation and insertion. ## Regulatory Identification A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system. ## Predicate Devices - Extremity Medical Screw and Washer System (IO FiX) ([K121417](/device/K121417.md)) - Nextremity Solutions InCore® Lapidus System ([K180257](/device/K180257.md)) - Nextremity Solutions InCore® TMT System ([K192578](/device/K192578.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services seal on the left and the FDA acronym along with the full name of the agency on the right. The FDA part of the logo is in blue, with the acronym in a square and the full name written out to the right of it. May 13, 2020 Nextremity Solutions. Inc. Elise Fox Quality and Regulatory Specialist 210 North Buffalo Street Warsaw, Indiana 46580 Re: K200124 Trade/Device Name: InCore MPJ System Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth Or Threaded Metallic Bone Fixation Fastener Regulatory Class: Class II Product Code: HWC Dated: January 17, 2020 Received: January 21, 2020 Dear Elise Fox: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal {1}------------------------------------------------ statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Shumaya Ali, MPH Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration # Indications for Use Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2020 See PRA Statement below. 510(k) Number (if known) ### K200124 Device Name InCore® MPJ System Indications for Use (Describe) The Nextremity Solutions InCore® MPJ System is a three-part construct intended for internal fixation for First Metatarsophalangeal Joint Arthrodesis (also known as 1st MPJ Fusion). Type of Use (Select one or both, as applicable) 区Prescription Use (Part 21 CFR 801 Subpart D) □Over-The-Counter Use (21 CFR 801 Subpart C) ### PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON A SEPARATE PAGE IF NEEDED #### FOR FDA USE ONLY Concurrence of Center for Devices and Radiological Health (CDRH) (Signature) {3}------------------------------------------------ | 510(k) Summary | | |-------------------|------------------------------------------------------------------------------------------------------------------------| | Prepared: | May 11th, 2020 | | Submitter: | Nextremity Solutions, Inc.
210 North Buffalo Street
Warsaw, IN 46580 | | Contact: | Elise Fox
Quality and Regulatory Specialist
elise.fox@nextremity.com
Phone: 574-376-2062
FAX: 574-966-1396 | | Proprietary Name: | InCore® MPJ System | | Common Name: | Bone Screw System | | Classification: | 21 CFR §888.3040: Smooth or threaded metallic bone fixation fastener;
Class II | | Product Code: | HWC | ### Substantially Equivalent Devices: - Extremity Medical Screw and Washer System (IO FiX), K121417 - Primary Predicate - . Nextremity Solutions InCore® Lapidus System. K180257- Additional Predicate - Nextremity Solutions InCore® TMT System, K192578- Additional Predicate ### Device Description: The InCore MPJ System consists of a post and two headless compression screws. Posts are available with a 4.9mm diameter, in an 18mm length, and left orientations. Screws are available in a 2.7mm diameter and lengths of 16 to 52mm. The post is inserted into the metatarsal head and compression screws are inserted into the phalange and into the post to maintain apposition of the bones during fusion. A post plug screw is threaded into the top of the post after all components have been implanted to prevent tissue ingrowth into the post and facilitate removal, if needed. All implants are manufactured from color anodized Ti-6Al-4V alloy conforming to ASTM F-136. {4}------------------------------------------------ The system is provided with a set of accessory instruments designed for preparation of the implant site and insertion of the implants into bone. #### Intended Use / Indications: The Nextremity Solutions InCore MPJ System is a three-part construct intended for internal fixation for First Metatarsophalangeal Joint Arthrodesis (also known as 1st MPJ Fusion). ### Summary of Technologies/Substantial Equivalence: The InCore MPJ System is substantially equivalent to the predicate devices in regard to its intended use and indications, material, design, sizes, and mechanical properties. Differences between the subject device system and the predicate device systems do not raise new types of safety and effectiveness questions. #### Non-Clinical Testing: Endotoxin testing was performed on another Nextremity product which is considered worst case. Results met the endotoxin limit of <20 EU / kit. During manufacturing, endotoxin testing will be conducted on the worst-case product in each sterilization lot. Endotoxin testing is performed using the Limulus Amebocyte Lysate (LAL) test Kinetic-Chromogenic Method according to the European Pharmacopeia and the United States Pharmacopeia. To evaluate the strength of the InCore MPJ System and components, axial pull-out strength, torque to failure, and 3-point bend tests were performed on worst case compression screws according to ASTM F543-13 and ASTM F1264-16. Static 3-point bend and dynamic 3-point bend tests were performed on worst case constructs according to ASTM F382-17. These tests confirmed that the strength of the InCore MPJ System is substantially equivalent to predicate devices with similar indications and is adequate for its intended use. #### Clinical Testing: Clinical testing was not necessary to demonstrate substantial equivalence of the InCore MPJ System to the predicate device. ## Conclusions/Substantial Equivalence: Differences between the subject device system and the predicate device systems do not raise new types of safety and effectiveness questions. The InCore MPJ System is substantially equivalent to the predicate devices in regard to its intended use, material, design, sizes, and mechanical properties. --- **Source:** [https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HWC/K200124](https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HWC/K200124) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com